Hypofractionated radiosurgery has a better safety profile than single fraction radiosurgery for large resected brain metastases
Authors:
- 11 April 2015
- journal article
- research article
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 123 (1) , 103-111
Abstract
The purpose of this study is to compare the safety and efficacy of single fraction radiosurgery (SFR) with hypofractionated radiosurgery (HR) for the adjuvant treatment of large, surgically resected brain metastases. Seventy-five patients with 76 resection cavities ≥ 3 cm received 15 Gray (Gy) × 1 SFR (n = 40) or 5–8 Gy × 3–5 HR (n = 36). Cumulative incidence of local failure (LF) and radiation necrosis (RN) was estimated accounting for death as a competing risk and compared with Gray’s test. The effect of multiple covariates was evaluated with the Fine-Gray proportional hazards model. The most common HR dose-fractionation schedules were 6 Gy × 5 (44 %), 7–8 Gy × 3 (36 %), and 6 Gy × 4 (8 %). The median follow-up was 11 months (range 2–71). HR patients had larger median resection cavity volumes (24.0 vs. 13.3 cc, p < 0.001), planning target volumes (PTV) (37.7 vs. 20.5 cc, p < 0.001), and cavity to PTV expansion margins (2 vs. 1.5 mm, p = 0.002) than SFR patients. Cumulative incidence of LF (95 % CI) at 6 and 12-months for HR versus SFR was 18.9 % (0.07–0.34) versus 15.9 % (0.06–0.29), and 25.6 % (0.12–0.42) versus 27.2 % (0.14–0.42), p = 0.80. Cumulative incidence of RN (95 % CI) at 6 and 12 months for HR vs. SFR was 3.3 % (0.00–0.15) versus 10.7 % (0.03–0.23), and 10.3 % (0.02–0.25) versus 19.2 % (0.08–0.34), p = 0.28. On multivariable analysis, SFR was significantly associated with an increased risk of RN, with a HR of 3.81 (95 % CI 1.04–13.93, p = 0.043). Hypofractionated radiosurgery may be the more favorable treatment approach for radiosurgery of cavities 3–4 cm in size and greater.Keywords
This publication has 27 references indexed in Scilit:
- Adjuvant therapy after resection of brain metastasesStrahlentherapie und Onkologie, 2013
- Hypofractionated radiosurgery for intact or resected brain metastases: defining the optimal dose and fractionationRadiation Oncology, 2013
- Radiosurgery to the Postoperative Surgical Cavity: Who Needs Evidence?International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Hypofractionated stereotactic radiotherapy (hfSRT) after tumour resection of a single brain metastasis: report of a single-centre individualized treatment approachJournal of Cancer Research and Clinical Oncology, 2012
- Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 StudyJournal of Clinical Oncology, 2011
- The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guidelineJournal of Neuro-Oncology, 2009
- Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trialThe Lancet Oncology, 2009
- A Proportional Hazards Model for the Subdistribution of a Competing RiskJournal of the American Statistical Association, 1999
- Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trialsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1997
- A Randomized Trial of Surgery in the Treatment of Single Metastases to the BrainNew England Journal of Medicine, 1990